expects to drive sales through its focus on growth opportunities in Indonesia and the private market in Malaysia while awaiting for the extension of its logistics and distribution agreement with the Health Ministry.
The logistic and distribution agreement is targeted to be executed in the fourth quarter of 2022, the pharmaceutical company said in a filing with Bursa Malaysia yesterday.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Gas Malaysia 2Q earnings soar 72%PETALING JAYA: Gas Malaysia Bhd, which posted a 72.2% jump in net profit to RM107.3mil in the second quarter ended June 30, will continue to take prudent measures to remain competitive.
Baca lebih lajut »